FDA Expands Approval of AJOVY as First Anti-CGRP Preventive for Pediatric Episodic Migraine Read more
FDA Accepts Bristol Myers Squibb’s Priority Review for Breyanzi in Relapsed/Refractory Marginal Zone Lymphoma Read more
FDA Advises Sarepta to Lift Pause and Resume ELEVIDYS Shipments for Ambulatory Duchenne Patients Read more
GSK and Hengrui Pharma Partner to Develop Up to 12 Innovative Medicines in Key Therapeutic Areas Read more